Capital International Investors 13D/13G Filings for Neurocrine Biosciences, Inc. (NBIX)

Capital International Investors 13D and 13G filings for Neurocrine Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
4:04 pm
Sale
2021-02-16 13G Neurocrine Biosciences, Inc.
NBIX
Capital International Investors 4,049,442
4.300%
-2,690,977decrease
(-39.92%)
Filing